Skip to main content
. 2021 Nov 4;9(11):1615. doi: 10.3390/biomedicines9111615

Figure 2.

Figure 2

A proposal of a hypothetical therapeutic flow-chart for atopic dermatitis that could be applied as soon as other biologics, in addition to dupilumab, are approved.